BloombergSen Inc. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.

Quarter-by-quarter ownership
BloombergSen Inc. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q3 2016$7,536,000
+21.9%
306,9660.0%0.74%
+12.9%
Q2 2016$6,182,000
-23.8%
306,966
-0.6%
0.65%
-19.4%
Q1 2016$8,118,000
-93.0%
308,666
-72.8%
0.81%
-90.6%
Q4 2015$115,530,000
-53.0%
1,136,554
-17.5%
8.56%
-36.6%
Q3 2015$245,827,000
-18.7%
1,378,108
+1.3%
13.50%
-12.2%
Q2 2015$302,291,000
+69.5%
1,360,752
+51.5%
15.37%
+39.2%
Q1 2015$178,356,000
+40.0%
897,976
+0.8%
11.04%
+22.4%
Q4 2014$127,429,000
-2.5%
890,4260.0%9.02%
-6.6%
Q3 2014$130,670,000
+20.2%
890,426
+3.3%
9.66%
+7.7%
Q2 2014$108,745,000
+8.0%
862,236
+24.4%
8.97%
+10.8%
Q1 2014$100,703,000
+23.7%
693,3810.0%8.09%
+16.0%
Q4 2013$81,403,000
+15.0%
693,381
+2.2%
6.98%
-7.3%
Q3 2013$70,811,000
+112.9%
678,719
+75.7%
7.53%
+84.2%
Q2 2013$33,253,000386,3004.09%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2015
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders